These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28271502)

  • 1. Trigonelline and vildagliptin antidiabetic effect: improvement of insulin signalling pathway.
    Aldakinah AA; Al-Shorbagy MY; Abdallah DM; El-Abhar HS
    J Pharm Pharmacol; 2017 Jul; 69(7):856-864. PubMed ID: 28271502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of Vildagliptin and Pioglitazone in Experimental Type 2 Diabetes in Male Rats.
    Refaat R; Sakr A; Salama M; El Sarha A
    Drug Dev Res; 2016 Sep; 77(6):300-9. PubMed ID: 27520857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vildagliptin added to metformin on β-cell function after a euglycemic hyperinsulinemic and hyperglycemic clamp in type 2 diabetes patients.
    Derosa G; Ragonesi PD; Carbone A; Fogari E; Bianchi L; Bonaventura A; Romano D; Cicero AF; Maffioli P
    Diabetes Technol Ther; 2012 Jun; 14(6):475-84. PubMed ID: 22512264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual therapy of vildagliptin and telmisartan on diabetic nephropathy in experimentally induced type 2 diabetes mellitus rats.
    Sharma AK; Kanawat DS; Mishra A; Dhakad PK; Sharma P; Srivastava V; Joshi S; Joshi M; Raikwar SK; Kurmi MK; Srinivasan BP
    J Renin Angiotensin Aldosterone Syst; 2014 Dec; 15(4):410-8. PubMed ID: 23396552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential effects of vildagliptin on biomarkers associated with prothrombosis in diabetes mellitus.
    Khan S; Khan S; Panda BP; Akhtar M; Najmi AK
    Expert Opin Ther Targets; 2015; 19(12):1607-16. PubMed ID: 26357866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihyperglycemic, hypolipidemic and antioxidant activities of total saponins extracted from Aralia taibaiensis in experimental type 2 diabetic rats.
    Weng Y; Yu L; Cui J; Zhu YR; Guo C; Wei G; Duan JL; Yin Y; Guan Y; Wang YH; Yang ZF; Xi MM; Wen AD
    J Ethnopharmacol; 2014 Mar; 152(3):553-60. PubMed ID: 24524879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of stevia aqueous extract on the antidiabetic activity of saxagliptin in diabetic rats.
    Abdel-Aal RA; Abdel-Rahman MS; Al Bayoumi S; Ali LA
    J Ethnopharmacol; 2021 Jan; 265():113188. PubMed ID: 32783985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of liver function, antioxidant responses, insulin resistance and glucose transport by Oroxylum indicum stem bark in STZ induced diabetic rats.
    Singh J; Kakkar P
    Food Chem Toxicol; 2013 Dec; 62():722-31. PubMed ID: 24140466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin sensitization via partial agonism of PPARγ and glucose uptake through translocation and activation of GLUT4 in PI3K/p-Akt signaling pathway by embelin in type 2 diabetic rats.
    Gandhi GR; Stalin A; Balakrishna K; Ignacimuthu S; Paulraj MG; Vishal R
    Biochim Biophys Acta; 2013 Jan; 1830(1):2243-55. PubMed ID: 23104384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochanin A improves insulin sensitivity and controls hyperglycemia in type 2 diabetes.
    Oza MJ; Kulkarni YA
    Biomed Pharmacother; 2018 Nov; 107():1119-1127. PubMed ID: 30257324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacological sheet. Vildagliptin, oral administration (GALVUS)].
    J Pharm Belg; 2009 Jun; (2):64-6. PubMed ID: 19739530
    [No Abstract]   [Full Text] [Related]  

  • 12. Combination therapy with metformin plus vildagliptin in type 2 diabetes mellitus.
    Guarino E; Nigi L; Patti A; Fondelli C; Dotta F
    Expert Opin Pharmacother; 2012 Jun; 13(9):1377-84. PubMed ID: 22397507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental diabetes treated with trigonelline: effect on β cell and pancreatic oxidative parameters.
    Zhou J; Zhou S; Zeng S
    Fundam Clin Pharmacol; 2013 Jun; 27(3):279-87. PubMed ID: 22172053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidiabetic activity of perylenequinonoid-rich extract from Shiraia bambusicola in KK-Ay mice with spontaneous type 2 diabetes mellitus.
    Huang M; Zhao P; Xiong M; Zhou Q; Zheng S; Ma X; Xu C; Yang J; Yang X; Zhang TC
    J Ethnopharmacol; 2016 Sep; 191():71-81. PubMed ID: 27286915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vildagliptin compared to glimepiride on post-prandial lipemia and on insulin resistance in type 2 diabetic patients.
    Derosa G; Bonaventura A; Bianchi L; Romano D; Fogari E; D'Angelo A; Maffioli P
    Metabolism; 2014 Jul; 63(7):957-67. PubMed ID: 24874591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Glycemic Control on Chylomicron Metabolism and Correlation between Postprandial Metabolism of Plasma Glucose and Chylomicron in Patients with Type 2 Diabetes Treated with Basal-bolus Insulin Therapy with or without Vildagliptin.
    Okajima F; Emoto N; Kato K; Sugihara H
    J Atheroscler Thromb; 2017 Feb; 24(2):157-168. PubMed ID: 27397060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vildagliptin: a review of its use in the management of type 2 diabetes mellitus.
    Croxtall JD; Keam SJ
    Drugs; 2008; 68(16):2387-409. PubMed ID: 18973400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vildagliptin selectively ameliorates GLP-1, GLUT4, SREBP-1c mRNA levels and stimulates β-cell proliferation resulting in improved glucose homeostasis in rats with streptozotocin-induced diabetes.
    Akarte AS; Srinivasan BP; Gandhi S
    J Diabetes Complications; 2012; 26(4):266-74. PubMed ID: 22626875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vildagliptin induces β-cell neogenesis and improves the lipid profile in a later phase of type 1 diabetes.
    de Amorim Miranda PH; Monteiro OM; Rossoni JV; Silva ME; de Lima WG; Costa DC
    Curr Pharm Biotechnol; 2015; 16(1):60-5. PubMed ID: 25395211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel long acting DPP-IV inhibitor PKF-275-055 stimulates β-cell proliferation resulting in improved glucose homeostasis in diabetic rats.
    Akarte AS; Srinivasan BP; Gandhi S
    Biochem Pharmacol; 2012 Jan; 83(2):241-52. PubMed ID: 22015634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.